Form D · Biotechnology
Mercury Bio, Inc.
Santa Fe, NM · CIK 0001952927
Offering snapshot reported Oct 24, 2025 · SEC filing
- Reported sold
- $2.38M Offering amount: $7.95M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 24, 2025 | Initial | $2,376,107 | No comparison | 6 | SEC filing |
| Feb 21, 2025 | Initial | $2,541 | No comparison | 1 | SEC filing |
| Apr 3, 2024 | Initial | $149,987 | No comparison | 2 | SEC filing |
| Feb 17, 2023 | Initial | $1,154,071 | No comparison | 8 | SEC filing |
| Nov 14, 2022 | Initial | $200,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-562001
Source: Form D, filed Oct 24, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dana Barnard | Director |
| Steve Buelow | Director |
| Steve Kiziuk | Director |
| Alex Koglin | Director |
| Paul Laur | Director, Executive |
| Bruce Mc Cormick | Director, Executive |
| Kevin Mc Donald | Director |
| Mike Rice | Director |
| Tuck Stibich | Director |
| John Tomes | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3900 Paseo Del Sol
Santa Fe, NM, 87507
Santa Fe, NM, 87507